Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
VEGF-A promotes angiogenesis in many tissues. Here we report that choroidal neovascularization (CNV) incited by injury was increased by excess VEGF-A before injury but was suppressed by VEGF-A after injury. This unorthodox antiangiogenic effect was mediated via VEGFR-1 activation and VEGFR-2 deactivation, the latter via Src homology domain 2-containing (SH2-containing) tyrosine phosphatase-1 (SHP-1). The VEGFR-1-specific ligand placental growth factor-1 (PlGF-1), but not VEGF-E, which selectively binds VEGFR-2, mimicked these responses. Excess VEGF-A increased CNV before injury because VEGFR-1 activation was silenced by secreted protein, acidic and rich in cysteine (SPARC). The transient decline of SPARC after injury revealed a temporal window in which VEGF-A signaling was routed principally through VEGFR-1. These observations indicate that therapeutic design of VEGF-A inhibition should include consideration of the level and activity of SPARC.
Document Type
Article
Publication Date
2-1-2006
Digital Object Identifier (DOI)
http://dx.doi.org/10.1172/JCI26316
Repository Citation
Nozaki, Miho; Sakurai, Eiji; Raisler, Brian J.; Baffi, Judit Z.; Witta, Jassir; Ogura, Yuichiro; Brekken, Rolf A.; Sage, E Helene; Ambati, Balamurali K.; and Ambati, Jayakrishna, "Loss of SPARC-Mediated VEGFR-1 Suppression After Injury Reveals a Novel Antiangiogenic Activity of VEGF-A" (2006). Ophthalmology and Visual Science Faculty Publications. 6.
https://uknowledge.uky.edu/ophthalmology_facpub/6
Notes/Citation Information
Published in The Journal of Clinical Investigation, v. 116, no. 2, p. 422-429.
The copyright holder has granted permission for posting the article here.